Back
FactSet Research Systems Vs. Edgewise Therapeutics Industry Stock Comparison
Buy
57
FDS
FactSet Research Systems
Last Price:
488.79
Seasonality Move:
-0.2%
Buy
60
EWTX
Edgewise Therapeutics
Last Price:
30.17
Seasonality Move:
30.89%
Buy
57
FactSet Research Systems (FDS)
is a Buy
Is FactSet Research Systems a Buy, Sell or Hold?
- The current FactSet Research Systems [FDS] share price is $488.81. The Score for FDS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- FDS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $30.17. The Score for EWTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FDS Stock Price Chart
What is FactSet Research Systems's stock price today?
-
The FactSet Research Systems share price today is $488.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDS is experiencing buying pressure, which is a positive indicator for future bullish movement.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $30.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.
FDS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.4 | Buy |
| Relative Strength Index (14 RSI): | 57.49 | Buy |
| Chaikin Money Flow: | 229038 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (481.3 - 491.04) | Buy |
| Bollinger Bands (100): | (422.04 - 481.2) | Buy |
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.67 | Sell |
| Relative Strength Index (14 RSI): | 46.31 | Sell |
| Chaikin Money Flow: | -1448657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.94 - 33.12) | Sell |
| Bollinger Bands (100): | (19.28 - 33.4) | Buy |
FDS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 485.66 | Buy |
| 20-day SMA: | 485.68 | Buy |
| 50-day SMA: | 474.74 | Buy |
| 200-day SMA: | 441.85 | Buy |
| 8-day EMA: | 486.94 | Buy |
| 20-day EMA: | 484.56 | Buy |
| 50-day EMA: | 474.59 | Buy |
| 200-day EMA: | 450.12 | Buy |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.09 | Buy |
| 20-day SMA: | 31.24 | Sell |
| 50-day SMA: | 32.59 | Sell |
| 200-day SMA: | 22.17 | Buy |
| 8-day EMA: | 30.32 | Sell |
| 20-day EMA: | 31.1 | Sell |
| 50-day EMA: | 30.61 | Sell |
| 200-day EMA: | 23.35 | Buy |
FactSet Research Systems Earnings Growth & FDS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.22 per share, and an increase next year of $0.89 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.30 per share.
FactSet Research Systems Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edgewise Therapeutics Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||